Evaluation of telemedicine medical abortion using a no‐test protocol in the Eastern Europe and Central Asian region: Evidence from Ukraine, Uzbekistan, and Azerbaijan
International Journal of Gynecology & Obstetrics · 2024
DOI: 10.1002/ijgo.15708 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Tamar Tsereteli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gynuity Health Projects, New York, New York, USA. Hauptthemen laut MEDLINE: Abortion, Induced, Telemedicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate safety, feasibility, and acceptability of a telemedicine medical abortion service without pre‐treatment in‐person tests in Ukraine, Uzbekistan, and Azerbaijan.
Methods
We conducted an open‐label, prospective, observational clinical study at five clinics in the three countries. Interested and eligible participants scheduled a telemedicine consultation with a study provider by phone or video. Medical abortion pills could be obtained by mail or courier or picked up at the study clinic or a pharmacy. Study providers contacted participants 1 week after mifepristone ingestion to assess abortion outcomes based on symptoms, and 3 weeks later to review the result of an at‐home, high‐sensitivity, urine pregnancy test. Participants were referred to in‐person visit based on symptoms, urine pregnancy test results, or initiative by the participant.
Results
In all, 300 women participated in the study. Almost all participants received medical abortion medications the same day as their first contact with the study clinic, and the majority ( n = 297, 99.0%) did not experience any problems receiving them. All except two women (0.67%) followed provider instructions on administration of medications. The majority of participants had a complete abortion without a procedure (Ukraine: n = 115, 95.8%; Uzbekistan: n = 127, 97.7%; Azerbaijan: n = 49, 98.0%), few had in‐person visits (Ukraine: n = 30, 25.0%; Uzbekistan: n = 3, 2.3%; Azerbaijan: n = 4, 8.0%), and most were very satisfied or satisfied with the service (Ukraine: n = 116, 96%; Uzbekistan: n = 128, 98%; Azerbaijan: n = 45, 90%). No serious adverse events occurred.
Conclusion
Telemedicine medical abortion using the no‐test protocol is safe, feasible and acceptable for women in Ukraine, Uzbekistan, and Azerbaijan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gynuity Health Projects, New York, New York, USA.
- New York University Grossman School of Medicine, New York, New York, USA.
- Charitable Foundation Women Health and Family Planning, Kyiv, Ukraine.
- Women's Wellness Center, Tashkent, Uzbekistan.
- Scientific-Research Institute of Obstetrics and Gynecology, Baku, Azerbaijan.
Zitieren
APA
Tsereteli, T., Platais, I., Maru, M., Maystruk, G., Kurbanbekova, D., Rzayeva, G., & Winikoff, B. (2024). Evaluation of telemedicine medical abortion using a no‐test protocol in the Eastern Europe and Central Asian region: Evidence from Ukraine, Uzbekistan, and Azerbaijan. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15708
Vancouver
Tsereteli T, Platais I, Maru M, Maystruk G, Kurbanbekova D, Rzayeva G, et al. Evaluation of telemedicine medical abortion using a no‐test protocol in the Eastern Europe and Central Asian region: Evidence from Ukraine, Uzbekistan, and Azerbaijan. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15708
BibTeX
@article{Tsereteli2024,
author = {Tsereteli, Tamar and Platais, Ingrida and Maru, Mahlet and Maystruk, Galyna and Kurbanbekova, Dilfuza and Rzayeva, Gulnara and Winikoff, Beverly},
title = {Evaluation of telemedicine medical abortion using a no‐test protocol in the Eastern Europe and Central Asian region: Evidence from Ukraine, Uzbekistan, and Azerbaijan},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
doi = {10.1002/ijgo.15708}
}
EUVIMED